Apollo Hospitals Enterprise Limited appears to be a financially healthy company, with strengths in earnings growth (53.5%) and gross margins (35.4%). However, the company's valuation is relatively high, with a trailing P/E of 69.43 and forward P/E of 85.86, indicating that the stock may be overpriced. The company's debt-to-equity ratio of 90.89 is a weakness, suggesting high leverage. Despite this, the company's profit margins and ROE are decent, indicating a stable profitability position. Overall, the company's financial health is good, but investors should be cautious of the high valuation and debt levels.